Literature DB >> 28893922

Challenges in Developing New Therapies for Vascular Access Dysfunction.

Karl A Nath1, Michael Allon2.   

Abstract

Entities:  

Keywords:  Arteriovenous Shunt; Surgical; arteriovenous fistula; arteriovenous graft; renal dialysis; vascular access

Mesh：

Year:  2017        PMID： 28893922      PMCID： PMC5718277          DOI： 10.2215/CJN.06650617

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Statin therapy is not associated with improved vascular access outcomes.

Authors:  Roberto Pisoni; Jill Barker-Finkel; Michael Allo
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

2.  Stent graft versus balloon angioplasty for failing dialysis-access grafts.

Authors:  Ziv J Haskal; Scott Trerotola; Bart Dolmatch; Earl Schuman; Sanford Altman; Samuel Mietling; Scott Berman; Gordon McLennan; Clayton Trimmer; John Ross; Thomas Vesely
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

3.  Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes.

Authors:  Marwan Tabbara; Juan C Duque; Laisel Martinez; Luis A Escobar; Wensong Wu; Yue Pan; Natasha Fernandez; Omaida C Velazquez; Edgar A Jaimes; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Am J Kidney Dis       Date:  2016-03-22       Impact factor: 8.860

Review 4.  Arteriovenous access failure: more than just intimal hyperplasia?

Authors:  Tonia C Rothuizen; Chunyu Wong; Paul H A Quax; Anton Jan van Zonneveld; Ton J Rabelink; Joris I Rotmans
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

5.  Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.

Authors:  Brenda R Hemmelgarn; Louise M Moist; Charmaine E Lok; Marcello Tonelli; Braden J Manns; Rachel M Holden; Martine LeBlanc; Peter Faris; Paul Barre; Jianguo Zhang; Nairne Scott-Douglas
Journal:  N Engl J Med       Date:  2011-01-27       Impact factor: 91.245

6.  Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial.

Authors:  Charmaine E Lok; Louise Moist; Brenda R Hemmelgarn; Marcello Tonelli; Miguel A Vazquez; Marc Dorval; Matthew Oliver; Sandra Donnelly; Michael Allon; Kenneth Stanley
Journal:  JAMA       Date:  2012-05-02       Impact factor: 56.272

7.  Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

Authors:  Laura M Dember; Gerald J Beck; Michael Allon; James A Delmez; Bradley S Dixon; Arthur Greenberg; Jonathan Himmelfarb; Miguel A Vazquez; Jennifer J Gassman; Tom Greene; Milena K Radeva; Gregory L Braden; T Alp Ikizler; Michael V Rocco; Ingemar J Davidson; James S Kaufman; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  JAMA       Date:  2008-05-14       Impact factor: 56.272

8.  Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse.

Authors:  J P Juncos; M J Tracz; A J Croatt; J P Grande; A W Ackerman; Z S Katusic; K A Nath
Journal:  Kidney Int       Date:  2008-03-26       Impact factor: 10.612

9.  Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes.

Authors:  Michael Allon; Michelle L Robbin; Carlton J Young; Mark H Deierhoi; Jeremy Goodman; Michael Hanaway; Mark E Lockhart; Silvio Litovsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

10.  A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1.

Authors:  Lu Kang; Joseph P Grande; Matthew L Hillestad; Anthony J Croatt; Michael A Barry; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-16
  10 in total
  4 in total

1.  Molecular Targets for Improving Arteriovenous Fistula Maturation and Patency.

Authors:  Jolanta Gorecka; Arash Fereydooni; Luis Gonzalez; Shin Rong Lee; Shirley Liu; Shun Ono; Jianbiao Xu; Jia Liu; Ryosuke Taniguchi; Yutaka Matsubara; Xixiang Gao; Mingjie Gao; John Langford; Bogdan Yatsula; Alan Dardik
Journal:  Vasc Investig Ther       Date:  2019-10-09

2.  Atorvastatin Reduces In Vivo Fibrin Deposition and Macrophage Accumulation, and Improves Primary Patency Duration and Maturation of Murine Arteriovenous Fistula.

Authors:  Jie Cui; Chase W Kessinger; Harkamal S Jhajj; Madeleine S Grau; Sanjay Misra; Peter Libby; Jason R McCarthy; Farouc A Jaffer
Journal:  J Am Soc Nephrol       Date:  2020-03-09       Impact factor: 10.121

3.  The murine dialysis fistula model exhibits a senescence phenotype: pathobiological mechanisms and therapeutic potential.

Authors:  Karl A Nath; Daniel R O'Brien; Anthony J Croatt; Joseph P Grande; Allan W Ackerman; Meryl C Nath; Satsuki Yamada; Andre Terzic; Tamara Tchkonia; James L Kirkland; Zvonimir S Katusic
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-18

4.  Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus.

Authors:  Po-Wei Chen; Ling-Wei Hsu; Hsien-Yuan Chang; Ting-Chun Huang; Jia-Rong Yu; Hsin-Yu Liao; Cheng-Han Lee; Ping-Yen Liu
Journal:  Biomed Res Int       Date:  2019-04-08       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.